The cessation occurred due to completion of her tenure as Independent Director. The company expressed appreciation for her valuable services and significant contributions during her tenure.
The disclosure includes Annexure-A with details as required under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, which specifies:
- Reason for change: Cessation due to tenure completion
- Date of cessation: August 21, 2026 (closing of business hours)
- The independent director holds no directorships in other listed entities
- The director provided confirmation that there are no other material reasons for cessation beyond those stated
Director's Resignation Letter Details
The enclosed letter from Dr. Manjula Anagani dated May 7, 2026, states that she decided not to seek re-appointment for a second term of five consecutive years upon completion of her first five-year term, citing pre-occupation and other professional commitments as reasons.
She explicitly confirmed that there are no other material reasons for her decision beyond those stated. The letter expresses appreciation for the cooperation, support, and trust extended by fellow directors, Key Managerial Personnel, and employees during her tenure.
Financial Impact
No financial impact quantified in the disclosure. This is a governance change without immediate financial implications.